Editorial: Bench to Bedside – the translation of intracortical inhibition marker to clinical practice

Article Sidebar

PDF
Published: Jan 5, 2023

Main Article Content

Danielle Carolina Pimenta
Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
https://orcid.org/0000-0001-6397-736X
Daniel Lima
Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Eric Slawka
Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Kevin Pacheco-Barrios
Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Felipe Fregni
Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

Abstract

Not applicable

Article Details

How to Cite
Editorial: Bench to Bedside – the translation of intracortical inhibition marker to clinical practice. (2023). Principles and Practice of Clinical Research, 8(3). https://doi.org/10.21801/ppcrj.2022.83.11
Issue
Vol. 8 No. 3 (2022): Principles and Practice of Clinical Research
Section
Notes from the Editors

How to Cite

Editorial: Bench to Bedside – the translation of intracortical inhibition marker to clinical practice. (2023). Principles and Practice of Clinical Research, 8(3). https://doi.org/10.21801/ppcrj.2022.83.11